← Open Payments lookup

KIMBERLY MILES: Open Payments

NPI 1811602469 · TROY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$778 in 27 payments from 7 companies in 2025. Trend: 2023 $260 · 2024 $187 · 2025 $778

Food & beverage: $778
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$218
Alkermes, Inc.7$201
Vanda Pharmaceuticals Inc.4$171
Neurocrine BioSciences, Inc.6$103
Teva Pharmaceuticals USA, Inc.2$43
Janssen Pharmaceuticals, Inc1$28
E.R. Squibb & Sons, L.L.C.1$15

Products named: CAPLYTA, FANAPT, ARISTADA, INGREZZA, LYBALVI, AUSTEDO XR, INVEGA SUSTENNA, COBENFY.

Industry payments across AL — which companies pay providers there.